This compound is a benzimidazole derivative featuring an ethyl ester and a cyano-substituted biphenyl moiety. It is primarily recognized as a pharmaceutical intermediate, with its crystal structure reported in the scientific literature.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 139481-41-7
Methyl 1-[(2'-cyano[1,1'-biphenyl]-4-yl)methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate
pharmaceutical intermediate
Ethyl 1-((2'-(1H-tetrazol-5-yl)-(1,1'-biphenyl)-4-yl)methyl)-2-ethoxy-1H-benzo(d)imidazole-7-carboxylate
pharmaceutical intermediate
2-Ethoxy-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid
Pharmaceutical intermediate for candesartan
16alpha-Hydroxyprednisolone
pharmaceutical raw material
2-(7-METHOXY-1-NAPHTHYL)ETHYLAMINE HYDROCHLORIDE
pharmaceutical intermediate
Ethyl 2-ethoxy-1-((2'-(N'-hydroxycarbamimidoyl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
pharmaceutical intermediate
Methyl 2-Ethoxy-1-[[2'-(hydroxyamidino)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate
Azilsartan intermediate
1-((2'-Carboxy-[1,1'-biphenyl]-4-yl)methyl)-4-methyl-2-propyl-1H-benzo[d]imidazole-6-carboxylic acid
pharmaceutical impurity reference standard
ethyl 3-[[4-(2-cyanophenyl)phenyl]methyl]-2-ethoxybenzimidazole-4-carboxylate
GYTTUVXCCHRIBA-UHFFFAOYSA-N
CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C#N)C(=O)OCC
—